Recent Advances in the Management of Preeclampsia

References

• “Obstetric-Gynecologic Terminology.”, H C Hughes. F.A. Davis Company, Philadelphia 1972; 422–423
   Google Scholar
• American College of Obstetricians and Gynecologists. “Management of Preeclampsia.”. American College of Obstetricians and Gynecologists, Washington, DC 1986, Technical Bulletin 91
   Google Scholar
• Sibai B M. Management of preeclampsia. Clin Perinatol 1991; 18: 793–808
   Google Scholar
• Gilstrap L C, Cunningham G F, Whalley P J. Management of pregnancy induced hypertension in the nulliparous patient remote from term. Semin Perinatol 1978; 2: 73–81
   Google Scholar
• Mathews D D. A randomized controlled trial of bed rest and sedation or normal activity and non-sedation in the management of non-albuminuric hypertension in late pregnancy. Br J Obstet Gynaecol 1977; 84: 108–110
   PubMedGoogle Scholar
• Feeney J G. Hypertension in pregnancy managed by community midwives. BMJ 1984; 288: 1046–1050
   PubMed Web of Science ®Google Scholar
• Tuffnell D J, Lilford R J, Buchan P C, Prendiville V M, Tuffnell A J, Holgate M P, Griffith-Jones M D. Randomised controlled trial of day care for hypertension in pregnancy. Lancet 1992; 339: 224–227
   PubMed Web of Science ®Google Scholar
• Crowther C A, Bouwmeester A M, Ashurst H M. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension?. Br J Obstet Gynaecol 1992; 99: 13–17
   PubMedGoogle Scholar
• Barton J R, Stanziano G J, Sibai B M. Monitored outpatient management of mild gestational hypertension remote from term. Am J Obstet Gynecol 1994; 170: 765–769
   PubMed Web of Science ®Google Scholar
• Helewa M, Heaman M, Robinson M A, Thompson L. Community-based home-care program for the management of pre-eclampsia: An alternative. Can Med Assoc J 1993; 149: 829–834
   Google Scholar
• Schiff E, Friedman S A, Sibai B M. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994; 84: 626–630
   PubMed Web of Science ®Google Scholar
• Railton A, Allen D G. Management and outcome of pregnancy complicated by severe pre-eclampsia of early onset. S Afr Med J 1987; 72: 608–610
   PubMed Web of Science ®Google Scholar
• Pattinson R C, Odendaal H J, du Toit R. Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J 1988; 73: 516–518
   PubMed Web of Science ®Google Scholar
• Banias B B, Devoe L D, Nolan T E. Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation. Am J Perinatol 1992; 9: 357–360
   PubMed Web of Science ®Google Scholar
• Olah K S, Redman C W, Gee H. Management of severe, early pre-eclampsia: Is conservative management justified?. Eur J Obstet Gynecol Reprod Biol 1994; 51: 175–180
   Google Scholar
• Moodley J, Korateng S A, Rout C. Expectant management of early onset of severe pre-eclampsia in Durban. S Afr Med J 1993; 83: 584–587
   PubMed Web of Science ®Google Scholar
• Sibai B M, Taslimi M, Abella T N, Brooks T F, Spinnato J A, Anderson G D. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 1985; 152: 32–37
   PubMed Web of Science ®Google Scholar
• Wisser W, van Pampus M G, Tretters P E, Walleburg H C. Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol, 53: 175–181
   Google Scholar
• Sibai B M, Akl S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990; 163: 733–738
   PubMed Web of Science ®Google Scholar
• Odendaal H J, Pattinson R C, Bam R, Grove D, Kotze T J. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: A randomized controlled trial. Obstet Gynecol 1990; 76: 1070–1075
   PubMed Web of Science ®Google Scholar
• Sibai B M, Mercer B M, Schiff E, Friedman S A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818–822
   PubMed Web of Science ®Google Scholar
• Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991; 77: 331–337
   PubMed Web of Science ®Google Scholar
• Pritchard J A, Cunningham F G, Pritchard S A. The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951–963
   PubMed Web of Science ®Google Scholar
• Lucas M J, Leveno K J, Cunningham F G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201–205
   PubMed Web of Science ®Google Scholar
• Moodley J, Moodley V V. Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy—the need for a large, randomized trial. Hyper Preg 1994; 13: 245–252
   Web of Science ®Google Scholar
• Sibai B M. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990; 162: 1141–1145
   PubMed Web of Science ®Google Scholar
• Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97: 104–109
   PubMedGoogle Scholar
• Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: A randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 110–117
   PubMedGoogle Scholar
• Ryan G, Lange I R, Naugler M A. Clinical experience with phenytoin prophylaxis in severe preeclampsia. Am J Obstet Gynecol 1989; 161: 1297–1304
   PubMed Web of Science ®Google Scholar
• Friedman S A, Lim K-H., Baker C A, Repke J T. Phenytoin versus magnesium sulfate in pre-eclampsia: A pilot study. Am J Perinatol 1993; 10: 233–238
   Google Scholar
• Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455–1463
   PubMed Web of Science ®Google Scholar
• Department of Health, Welsh Office, Scottish Home and Health Department, Department of Health and Social Security, Northern Ireland. “Report on Confidential Enquiries Into Maternal Deaths in the United Kingdom 1988–1990”. HM Stationery Office, London 1994
   Google Scholar
• Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99: 547–553
   PubMedGoogle Scholar
• McGuiness G A, Weinstein M M, Cruikshank D P, Pitkin R M. Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses. Obstet Gynecol 1980; 56: 595–600
   Google Scholar
• Burrows R F, Burrows E A. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorder of pregnancy. Am J Obstet Gynecol 1995; 173: 929–935
   PubMedGoogle Scholar
• Ylikorkala O, Makila U M, Kaapa P, Viinikka L. Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans. Am J Obstet Gynecol 1986; 155: 345–349
   PubMed Web of Science ®Google Scholar
• Barton J R, Sibai B M. Low-dose aspirin to improve perinatal outcome. Clin Obstet Gynecol 1991; 34: 251–261
   Google Scholar
• Beaufils M, Uzan S, Donsimoni R, Colau J C. Prevention of preeclampsia by early antiplatelet therapy. Lancet 1985; 2: 840–842
   Google Scholar
• Wallenburg H LS, Dekker G A, Makowitz J W. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3
   PubMed Web of Science ®Google Scholar
• Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Piniroli V, Fanelli R, Gastaldi A, Remuzzi G. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk of pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–362
   PubMed Web of Science ®Google Scholar
• Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Uahal I, Blankstein J, Goldman B, Mashiach S. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351–356
   PubMed Web of Science ®Google Scholar
• Dekker G A, Sibai B M. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 1993; 168: 214–227
   PubMed Web of Science ®Google Scholar
• Sibai B M, Caritis S N, Thom E, Klebanoff M, McNeills D, Rocco L, Paul R H, Romero R, Witter F, Rosen M, Depp R, the NICHD Network. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 1213–1218
   PubMed Web of Science ®Google Scholar
• CLASP. a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9384 pregnant women. Lancet 1994; 343: 619–629
   PubMed Web of Science ®Google Scholar
• Italian Study of Aspirin in Pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy induced hypertension. Lancet 1993; 341: 753–754
   Google Scholar
• Belizan J M, Villar J. The relationship between calcium intake and edema proteinuria- and hypertension-gestosis: An hypothesis. Am J Clin Nutr 1980; 33: 2202–2210
   PubMed Web of Science ®Google Scholar
• Belizan J M, Villar J, Repke J. The relationship between calcium intake and pregnancy-induced hypertension: Up-to-date evidence. Am J Obstet Gynecol 1988; 158: 898–902
   PubMed Web of Science ®Google Scholar
• Belizan J M, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991; 325: 1399–1405
   PubMed Web of Science ®Google Scholar
• Caroli G, Duley L, Belizan J M, Villar J. Calcium supplementation during pregnancy: A systematic review of randomised controlled trials. Br J Obstet Gynaecol 1994; 101: 753–758
   Google Scholar